Crossmark

Evaluation of lung adverse events with nivolumab using the spontaneous reporting system in Japan

Published Online: 2023-05-31

Authors

Kanbayashi, Yuko

Shimizu, Tadashi

Kojima, Asuka

Anzai, Miku

Kawai, Rika

Uchida, Mayako
License Information

Text and Data Mining valid from 2023-05-31

Version of Record valid from 2023-05-31
More Information

Article History

Received: 26 January 2023

Accepted: 20 May 2023

First Online: 31 May 2023

Competing interests

: The authors declare no competing interests.

Document is current